DB
PCYC

Dmitry Balyasny’s PHARMACYCLICS INC PCYC Stock Holding History

Dmitry Balyasny’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-56,563
Closed -$4.5M – 806
2013
Q2 		$4.5M Buy
+56,563
New +$4.62M 0.08% 311

Other funds holding PCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dmitry Balyasny's PCYC Position: Q3 2013 in Review

Dmitry Balyasny sold out of PHARMACYCLICS INC (PCYC) in Q3 2013, closing a stake of 56,563 shares — an estimated $4.5M sold.

Dmitry Balyasny first reported a position in PCYC in Q2 2013 and held it in 1 quarter. The position peaked at $4.5M in Q2 2013. 224 funds tracked by Wall St. Rank hold PCYC as of Q3 2013.

  • Dmitry Balyasny reported no remaining PHARMACYCLICS INC position as of Q3 2013 after selling out during the quarter.
  • Dmitry Balyasny sold 56,563 PHARMACYCLICS INC shares in Q3 2013, an estimated $4.5M.
  • Dmitry Balyasny first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 1 quarter.
  • Dmitry Balyasny's PHARMACYCLICS INC position peaked at $4.5M in Q2 2013.
  • 224 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q3 2013.

Based on Balyasny Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.